4
Changes in Ownership
Xenetic Biosciences, Inc. Filed Acc 0001683168-22-002000
Options or other derivatives
- Chief Executive Officer acquired 100,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| EISENBERG JEFFREY F Chief Executive Officer | 2022-03-24 | Grant or award · Stock Options | +100,000 | 100,000 | D: show line 1 in the form |
Loading xslF345X03/ownership.xml…